Increased levels of tumor necrosis alpha and soluble vascular endothel adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis

Acta Microbiologica et Immunologica Hungarica

Volumn 50, Issue 4, 2003, Pages 339-348

  Baraczka, Krisztina ^a,d   Pozsonyi, Teréz ^b   Szüts, Ildikó ^a   Ormos, G ^a   Nekam K ^c  

^a NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Polyclin Hospitaller Bros St J   (Hungary)

^d NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

Author keywords

CSF; CTDs; MS; sVCAM 1; TNF alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; AUTOANTIBODY;

ADULT; ARTICLE; BRAIN BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROPSYCHIATRY; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SOLUBILITY; BLOOD; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DISEASES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 1442354081     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: 10.1556/AMicr.50.2003.4.3     Document Type: Article

References (29)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. ACR ad hoc committee of neuropsychiatric lupus nomenclature. Arthritis and Rheumatism 42, 599-608 (1999).
2. Hietaharju, A., Yli Kerttula, U., Hakkinen, V., Frey, H.: Nervous system manifestations in Sjogrens syndrome. Acta Neurol Scand 81, 144-152 (1990).
3. Nadeau, S. E.: Neurologic manifestations of connective tissue disease. Neurol Clin 20, 151-178 (2002).
4. Lindvall, B., Bengtsson, A., Ernerudh, J., Eriksson, P.: Subclinical myositis is common in primary Sjogrens Syndrome and is not related to muscle pain. J Rheumatol 29, 717-725 (2002).
5. Kinnunen, E., Muller, K., Keto, P., Ketonen, L., Helve, T., Sepponen, R.: Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol Scand 87, 356-360 (1993).
6. Hietaharju, A., Peltola, J., Seppa, J., Luukkainen, R., Dastidar, P.: The coexistence of systemic lupus erythematosus and multiple sclerosis in a mother and daughter. Scand J Rheumatol 30, 120-122 (2001).
7. Iniguez, C., Mauri, J., Medrano, M., Larrode, P., Santos, S., Pina, J., Morales, F.: Sjogren's syndrome and multiple sclerosis. Neurologia 16, 232-235 (2001) (Spain).
8. Kanellopoulos, P., Baltoyiannis, C., Tzioufas, A. G.: Primary Sjogrens syndrome associated with inclusion body myositis. Rheumatology 41, 440-444 (2002).
9. Baraczka, K., Lakos, G., Sipka, S.: Immunoserological changes in the cerebrospinal fluid and serum in systemic lupus erythematosus patients with demyelinating syndrome and multiple sclerosis. Acta Neurol Scand 105, 378-383 (2002).
10. Christenson, R. H., Behlmer, P., Howard, J. F. Jr., Winfield, J. B., Silverman, L. M.: Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. Clin Chem 29, 1028-1030 (1983).
11. Beebe, A. M., Cua, D. J., de Waal Malefyt, R.: The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13, 403-412 (2002).
12. Baraczka, K., Nekam, K., Pozsonyi, T., Jakab, L., Szongoth, M., Sesztak, M.: Concentrations of soluble adhesion molecules (sVCAM-1, sICAM-1 and sLselectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous system involvement. Neuroimmunomodulation 9, 49-54 (2001).
13. Hummel, V., Kalmann, B. A., Wagner, S., Fuller, T., Bayas, A., Tonn, J. C., Benveniste, E. N., Toyka, K. V., Rieckmann, P.: Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J Neuropathol Exp Neurol 60, 320-327 (2001).
14. Sharief, M. K., Noori, M. A., Ciardi, M., Cirelli, A., Thompson, E. J.: Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol 434, 15-21 (1993).
15. Nagahama, M., Nomura, S., Ozaki, Y., Yoshimura, C., Kagawa, H., Fukuhara, S.: Platelet activation markers and soluble adhesion molecule in patients with systemic lupus erythematosus. Autoimmunity 33, 85-94 (2001).
16. Poser, C. M., Brinar, V. V.: Diagnostic criteria for multiple sclerosis. Clin Neur Neurosurg 103, 1-11 (2001).
17. Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., Winchester, R. J.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 25, 1271-1277 (1982).
18. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., Pillmer, S. R., Talal, N., Weisman, M. H., and the European Study Group on classification criteria for Sjogrens Syndrome. Classification criteria for Sjogrens syndrome: a revised version of the European criteria proposed by American-European Consensus group. Ann Rheumat Dis 61, 554-558 (2002).
19. Link, H., Tibling, G.: Principles of albumin and IgG analysis in neurological disorders. Scand J Lab Invest 37, 385-396 (1977).
20. McDonnell, G. V., McMillan, S. A., Douglas, J. P., Droogan, A. G., Hawkins, S. A.: Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease. J Neurol 246, 87-92 (1999).
21. Sharief, M. K., Thompson, E. J.: In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 38, 27-33 (1992).
22. Dore-Duffy, P., Newman, W., Balabanov, R., Lisak, R. P., Mainolfi, E., Rothlein, R., Peterson, M.: Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 37, 55-62 (1995).
23. Gattorno, M., Vignola, S., Barbano, G., Sormani, M. P., Sabatini, F., Biocompagni, A., Picco, P., Pistoia, V.: Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus. J Rheumatol 27, 2251-2255 (2000).
24. Neidhart, M., Pataki, F., Fehr, K.: Increased soluble endothel adhesion molecules in rheumatoid arthritis correlate with circulating cytokines and depletion of CD45Ro+ T-lymphocytes from blood stream. Schweiz Med Wochenschrift 125, 424-428 (1995).
25. Giovannoni, G., Miller, D. H., Losseff, N. A., Sailer, M., Lewellyn-Smith, N., Thompson, A. J., Thompson, E. J.: Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J Neurol 248, 487-495 (2001).
26. Vladic, A., Horvat, G., Vukadin, S., Sucic, Z., Simaga, S.: Cerebrospinal fluid and serum protein levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients. Cytokine 20, 86-89 (2002).
27. Sharief, M. K.: Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis. Eur J Neurol 9, 49-54 (2002).
28. Pashenkov, M., Soderstrom, M., Huang, Z. M., Link, H.: Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells. Clin Exp Immunol 128, 379-387 (2002).
29. Frigerio, S., Gelati, M., Ciusani, E., Corsini, E., Dufour, A., Massa, G., Salmaggi, A.: Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1, sVCAM-1. J Neurol 245, 727-730 (1998).